Skip to main content
Top
Published in: Critical Care 1/2020

01-12-2020 | Epstein-Barr Virus | Research Letter

Correlation of interleukin-6 with Epstein–Barr virus levels in COVID-19

Authors: Georg Franz Lehner, Sebastian Johann Klein, Heinz Zoller, Andreas Peer, Romuald Bellmann, Michael Joannidis

Published in: Critical Care | Issue 1/2020

Login to get access

Excerpt

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) pneumonia with respiratory failure in a subset of infected patients. To date, it is unclear which factors trigger or cause the severe course of disease. Moreover, there is only limited evidence concerning extrapulmonary manifestations of COVID-19. …
Literature
1.
go back to reference Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.CrossRef Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.CrossRef
2.
go back to reference Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4.CrossRef Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4.CrossRef
3.
go back to reference Glaser R, Litsky ML, Padgett DA, Baiocchi RA, Yang EV, Chen M, et al. EBV-encoded dUTPase induces immune dysregulation: implications for the pathophysiology of EBV-associated disease. Virology. 2006;346(1):205–18.CrossRef Glaser R, Litsky ML, Padgett DA, Baiocchi RA, Yang EV, Chen M, et al. EBV-encoded dUTPase induces immune dysregulation: implications for the pathophysiology of EBV-associated disease. Virology. 2006;346(1):205–18.CrossRef
4.
go back to reference LeClaire AC, Martin CA, Hoven AD. Rash associated with piperacillin/tazobactam administration in infectious mononucleosis. Ann Pharmacother. 2004;38(6):996–8.CrossRef LeClaire AC, Martin CA, Hoven AD. Rash associated with piperacillin/tazobactam administration in infectious mononucleosis. Ann Pharmacother. 2004;38(6):996–8.CrossRef
5.
go back to reference Thompson DF, Ramos CL. Antibiotic-induced rash in patients with infectious mononucleosis. Ann Pharmacother. 2017;51(2):154–62.CrossRef Thompson DF, Ramos CL. Antibiotic-induced rash in patients with infectious mononucleosis. Ann Pharmacother. 2017;51(2):154–62.CrossRef
6.
go back to reference Ong DSY, Bonten MJM, Spitoni C, Lunel FMV, Frencken JF, Horn J, et al. Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock. Clin Infect Dis. 2017;64(9):1204–10.CrossRef Ong DSY, Bonten MJM, Spitoni C, Lunel FMV, Frencken JF, Horn J, et al. Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock. Clin Infect Dis. 2017;64(9):1204–10.CrossRef
Metadata
Title
Correlation of interleukin-6 with Epstein–Barr virus levels in COVID-19
Authors
Georg Franz Lehner
Sebastian Johann Klein
Heinz Zoller
Andreas Peer
Romuald Bellmann
Michael Joannidis
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-020-03384-6

Other articles of this Issue 1/2020

Critical Care 1/2020 Go to the issue